Plain-English translation of NCT05582551 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a screening tool called HPARSS (Highlighting Patients At Risk for Sensory Screening) that helps doctors identify which young cancer survivors might have developed hearing loss or nerve damage from their past treatment. The goal is to catch these problems earlier so they can be properly diagnosed and treated before they affect daily life.
Many childhood cancer survivors develop hearing or nerve problems as a long-term side effect of chemotherapy and radiation, but these issues are often missed because doctors don't have a clear way to know which patients to screen. This study aims to solve that problem by creating a tool that flags at-risk patients and guides doctors to perform the right screening tests.
You likely qualify if…
You likely don't qualify if…
You would come to a clinic appointment where your care team uses the screening tool to check if you might be at risk for hearing or nerve problems based on your specific cancer treatment. If the screening suggests you might have an issue, your doctor will arrange additional testing or referrals to specialists who can diagnose and help treat the problem. Your parents or guardians will also be asked some questions about the screening process.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States